Humana Inc. (HUM) - Stock Analysis

Medical - Healthcare Plans
Healthcare

Humana Inc.

HUM · US · NYSE

355.25

USD

-1.04

(0.29%)

14.21

EPS
25.01

P/E
42.8B

MARKET CAP
1.00%

DIV YIELD

Company Overview

500 W MAIN ST,LOUISVILLE KY 40202,5025801000

CEO

Mr. James A. Rechtin M.B.A.

Employess

65000

Sector

Healthcare

Industry

Medical - Healthcare Plans

Website

https://www.humana.com

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Next Earnings Date

Nov. 6, 2024

Ex Dividends date

Jul. 26, 2024

Dividend Date

June 28, 2024

YTD Performance

-24.43%

Fiscal Year End

12-31

IPO Date

1981-12-31

Growth Rates

(avg. rate of change)	10 years	5 years	3 years	1 year
Sales/Revenue	9.92%	13.33%	11.30%	14.54%
EPS	9.91%	10.42%	-7.60%	-9.50%
Equity	5.73%	9.86%	5.81%	6.21%
Cash	15.22%	14.91%	0.15%	-7.25%
Return On Capital (ROIC)	11.74%	13.15%	10.83%	10.22%

Debt

year (millions)	2023	2022	2021	2020	2019
Short Term Debt	1,610	2,390	2,280	920	924
Long Term Debt	10,200	9,030	10,500	6,060	4,970
LT Finance Leases	444	456	546	355	332
Shares Outstanding	124	126	129	132	134
Market Cap	56,700	64,800	59,700	54,200	49,100

Price

Business Segments (Beta)

Geographical Segments (Beta)

Not available

News

The Schall Law Firm Urges Shareholders Who Sustained Losses With Humana Inc To Initiate Dialogue

1 month

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 2, 2024.

accesswire.com

HUMANA ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months

NEW YORK, Aug. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024. Our investigation concerns whether the board of directors of Humana have breached their fiduciary duties to the company.

globenewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. – HUM

2 months

NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com

HUM LAWSUIT ALERT: Levi & Korsinsky Notifies Humana Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

2 months

NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=93651&wire=1 or contact Joseph E. Levi, Esq.

accesswire.com

FINAL HUM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Humana Inc. Investors to Join the Class Action Lawsuit!

2 months

NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").

accesswire.com

Investors in Humana Inc. Should Contact Levi & Korsinsky Before August 2, 2024 to Discuss Your Rights - HUM

2 months

accesswire.com

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humana

2 months

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Humana To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Humana To Contact Him Directly To Discuss Their Options

globenewswire.com

Shareholders that Lost Money on Humana Inc. (HUM) Should Contact Levi & Korsinsky About Pending Class Action - HUM

2 months

accesswire.com

Humana Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 2, 2024 to Discuss Your Rights - HUM

2 months

NEW YORK , Aug. 2, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Humana Inc. ("Humana" or the "Company") (NYSE: HUM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Humana investors who were adversely affected by alleged securities fraud between July 27, 2022 and January 24, 2024.

prnewswire.com

Levi & Korsinsky Reminds Humana Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 2, 2024 – HUM

2 months

NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/humana-lawsuit-submission-form?prid=93455&wire=1 or contact Joseph E. Levi, Esq.

accesswire.com

Levi & Korsinsky Reminds Humana Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 2, 2024 - HUM

2 months

accesswire.com

Class Action Filed Against Humana Inc. (HUM) - August 2, 2024 Deadline to Join – Contact Levi & Korsinsky

2 months

accesswire.com